K161332 is an FDA 510(k) clearance for the NILE Proximal Fixation Spinal System. Classified as Bone Fixation Cerclage, Sublaminar (product code OWI), Class II - Special Controls.
Submitted by K2m, Inc. (Leesburg, US). The FDA issued a Cleared decision on April 5, 2017 after a review of 328 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3010 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.
View all K2m, Inc. devices